Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 6, Pages 11190-11207
Publisher
MDPI AG
Online
2013-05-27
DOI
10.3390/ijms140611190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 14q32 MicroRNA-487b Targets the Antiapoptotic Insulin Receptor Substrate 1 in Hypertension-Induced Remodeling of the Aorta
- (2013) A. Yaël Nossent et al. ANNALS OF SURGERY
- Endothelin in hypertension
- (2012) Yohann Rautureau et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Small RNA Sequencing Reveals MicroRNAs That Modulate Angiotensin II Effects in Vascular Smooth Muscle Cells
- (2012) Wen Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SNPs in MicroRNA Binding Sites in 3′-UTRs of RAAS Genes Influence Arterial Blood Pressure and Risk of Myocardial Infarction
- (2011) A Yaël Nossent et al. AMERICAN JOURNAL OF HYPERTENSION
- Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration
- (2011) Ni Zhu et al. ATHEROSCLEROSIS
- Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes
- (2011) Pia Lindgren Jeppesen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132
- (2011) Rajesh Katare et al. CIRCULATION RESEARCH
- Fibulin-1 Is a Marker for Arterial Extracellular Matrix Alterations in Type 2 Diabetes
- (2011) C. Cangemi et al. CLINICAL CHEMISTRY
- MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets
- (2011) Sándor Bátkai et al. CURRENT HYPERTENSION REPORTS
- MicroRNA212/132 family: Molecular transducer of neuronal function and plasticity
- (2011) Paola Tognini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Under pressure: the search for the essential mechanisms of hypertension
- (2011) Thomas M Coffman NATURE MEDICINE
- MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes
- (2010) Ditte C. Andersen et al. EXPERIMENTAL CELL RESEARCH
- Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists
- (2010) Gitte L. Christensen et al. MOLECULAR & CELLULAR PROTEOMICS
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis
- (2010) Sudarshan Anand et al. NATURE MEDICINE
- MicroRNA 132 Regulates Nutritional Stress-Induced Chemokine Production through Repression of SirT1
- (2009) Jay C. Strum et al. MOLECULAR ENDOCRINOLOGY
- Murine “Cardiospheres” Are Not a Source of Stem Cells with Cardiomyogenic Potential
- (2009) Ditte Caroline Andersen et al. STEM CELLS
- Toward MicroRNA–Based Therapeutics for Heart Disease
- (2008) Eva van Rooij et al. CIRCULATION RESEARCH
- The human angiotensin AT1 receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferation
- (2008) Jakob Lerche Hansen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Update on tissue renin–angiotensin systems
- (2008) Michael Bader et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now